Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LV.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GE.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GE.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
GE.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GE.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.2.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.2.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.2.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JC.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KE.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KE.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KE.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.8.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.8.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.30ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.56ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.56ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.56NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.1.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JD.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JD.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDTORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDTENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDTENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used